Phase 3 Myeloma Trial, Recruiting NCT07202078 Sponsor: Monash University Condition: Myeloma
Back to Myeloma

Phase 3 Myeloma Trial, Recruiting

NCT07202078
Recruiting Phase 3 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The inclusion criteria section does not list any specific requirements for joining this part of the trial (confirm with trial site)

Who may not be able to join:

  • People who have previously had, or are planned to have, a stem cell transplant using cells from another person
  • People who are already taking antibiotic tablets, capsules, or infusions specifically to prevent bacterial infections (note: preventive treatments for viral, fungal, or a specific lung infection called PJP are not a barrier)
  • People who have received an immunoglobulin infusion or injection in the past three months
  • People who have objections to receiving immunoglobulin products (a type of treatment made from donated blood)
  • People who have a known condition called IgA deficiency combined with anti-IgA antibodies
  • People with a history of a severe allergic reaction to immunoglobulin products
  • People who currently have an active infection that is being treated with antibiotics
  • People who are allergic or intolerant to all of the antibiotic options available in this part of the trial
  • People who are pregnant or breastfeeding
  • People with severely reduced kidney function (confirm with trial site for the specific measurement used)
  • People who have previously had their spleen removed
  • People who have already taken part in this section of the trial before
  • People whose treating doctor considers that joining this part of the trial would not be in their best interest

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Zoe McQuilten, Professor, Monash University

Australian sites

Royal Adelaide Hospital, Adelaide, South Australia
+61 (8) 7074 5898
Austin Hospital, Melbourne, Victoria
+61 (03) 9070 5741
Northern Health, Melbourne, Victoria
+61 (03) 8408 6000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Monash University
Registry
ClinicalTrials.gov
Start date
7 May 2025
Est. completion
31 March 2027

Where this trial is recruiting

🇦🇺 Australia

3 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Event-free survival (EFS).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov